Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas

Eur J Surg Oncol. 2023 Jun;49(6):1061-1067. doi: 10.1016/j.ejso.2022.05.010. Epub 2022 May 16.

Abstract

Until recently, the recommendation for primary retroperitoneal sarcomas (RPS) was to perform a complete en-bloc gross excision, (neo) adjuvant treatments being options which were not validated by randomized studies, with a large discrepancy of use between centers. The heterogeneity of RPS, with their different biological behaviour, renders a homogenous therapeutic and surgical approach probably inappropriate. Recent studies, both surgical and dedicated to adjuvant treatments, allow refining these recommendations. This review summarizes recent advances and directions.

Keywords: Chemotherapy; Diagnosis; Liposarcoma; Radiotherapy; Retroperitoneal sarcoma; Retroperitoneal tumour; Solitary fibrous Tumor; Surgery; leiomyosarcoma.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasm Recurrence, Local / therapy
  • Retroperitoneal Neoplasms* / surgery
  • Retrospective Studies
  • Sarcoma* / surgery
  • Survival Rate